Article
Immune Subtypes and Survival in Patients with Primary Glioma
2026-04-30
Abstract excerpt
<h4>Background</h4> Gliomas are heterogeneous tumors with poor outcomes following current therapies, including immunotherapy. The tumor microenvironment (TME) is a critical determinant of therapeutic response in gliomas. We have classified the immune TME of gliomas by multiplex immunofluorescence (mIF). <h4>Methods</h4> Tissue taken at initial resection from 354 patients with newly−diagnosed glioma grades 2-4 we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a3838ed-35ec-5c68-b143-86892bc9ef38
- DOI
- 10.64898/2026.04.29.26351981
